Literature DB >> 8434096

States' responses to Title II of the Ryan White CARE Act.

M M McKinney1, M K Wieland, G S Bowen, E P Goosby, K M Marconi.   

Abstract

Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act of 1990 provides formula-based grants to States to help them improve the quality, availability, and organization of health care and support services for people with human immunodeficiency virus (HIV) infection. This article reviews State expenditures during the first year of CARE Act funding (April 1991-March 1992) within the context of Title II guidelines and the federally funded grant programs that preceded and helped shape Title II. The authors also discuss future challenges that require development of resources, the assessment of program impact, and the evaluation of the quality and appropriateness of HIV-related services. Ninety-one percent of the $77.5 million awarded to States during fiscal year 1991 went for the provision of medical and support services through HIV care consortia, drug reimbursement programs, home and community-based care programs, and health insurance initiatives. The remaining monies were used for planning, evaluation, and program administration. Forty States allocated $38.9 million for the establishment of HIV care consortia to assess service needs and to develop comprehensive continuums of health and support services in the areas most affected by HIV disease. Fifty States allocated an additional $28.3 million for the continuation or expansion of FDA-approved drug therapies for low-income people with HIV infection. Twenty-five States allocated $2.2 million for the provision of home- and community-based health services, and 16 States allocated $1.3 million for programs that help low-income people with HIV infection to purchase or maintain health insurance coverage.

Entities:  

Mesh:

Year:  1993        PMID: 8434096      PMCID: PMC1403324     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  3 in total

1.  From the Health Care Financing Administration.

Authors:  G R Wilensky
Journal:  JAMA       Date:  1991-12-25       Impact factor: 56.272

2.  Forecasts of the costs of medical care for persons with HIV: 1992-1995.

Authors:  F J Hellinger
Journal:  Inquiry       Date:  1992       Impact factor: 1.730

3.  Economic consequences for Medicaid of human immunodeficiency virus infection.

Authors:  M A Baily; L Bilheimer; J Wooldridge; K Langwell; W Greenberg
Journal:  Health Care Financ Rev       Date:  1990-12
  3 in total
  4 in total

1.  Trends in Racial/Ethnic Disparities Among Patients Living with HIV in Texas, 1996 to 2013.

Authors:  Sabina O Nduaguba; Kentya H Ford; James P Wilson; Kenneth A Lawson
Journal:  J Racial Ethn Health Disparities       Date:  2017-12-21

2.  Compliance with public sector HIV medical care.

Authors:  P Kissinger; D Cohen; W Brandon; J Rice; A Morse; R Clark
Journal:  J Natl Med Assoc       Date:  1995-01       Impact factor: 1.798

3.  State Implementation of the AIDS Drug Assistance Programs.

Authors:  Robert J Buchanan; Scott R Smith
Journal:  Health Care Financ Rev       Date:  1998

4.  Medicaid policies for HIV-related prescription drugs.

Authors:  R J Buchanan; S R Smith
Journal:  Health Care Financ Rev       Date:  1994
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.